PRLD · Categories · Form 3

PRLD - SEC Form 3 initial insider statements

Prelude Therapeutics Incorporated (PRLD) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for PRLD

• 40d
  New insider Ra Capital Management, L.P. claimed ownership of 7,882,882 shares (SEC Form 3)

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 53d
  SEC Form 3 filed by new insider Morris Charles Q

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 80d
  SEC Form 3 filed by new insider Brusky Sean P.

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 230d
  SEC Form 3 filed by new insider Dorton Katina

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 359d
  SEC Form 3 filed by new insider Scherer Paul C

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1201d
  SEC Form 3 filed by new insider Lim Bryant David

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1523d
  SEC Form 3 filed by new insider Huang Jane

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)
• 1649d
  SEC Form 3: New insider Chardonnet Laurent claimed ownership of 3,000 shares

  3 - Prelude Therapeutics Inc (0001678660) (Issuer)

Other PRLD categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends